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Background: Bovine respiratory disease complex (BRDC) is an infectious disease of cattle that is caused by a
combination of viral and/or bacterial pathogens. Selection for cattle with reduced susceptibility to respiratory
disease would provide a permanent tool for reducing the prevalence of BRDC. The objective of this study was to
identify BRDC susceptibility loci in pre-weaned Holstein calves as a prerequisite to using genetic improvement as a
tool for decreasing the prevalence of BRDC. High density SNP genotyping with the Illumina BovineHD BeadChip
was conducted on 1257 male and 757 female Holstein calves from California (CA), and 767 calves identified as
female from New Mexico (NM). Of these, 1382 were classified as BRDC cases, and 1396 were classified as controls,
with all phenotypes assigned using the McGuirk health scoring system. During the acquisition of blood for DNA
isolation, two deep pharyngeal and one mid-nasal diagnostic swab were obtained from each calf for the identification
of bacterial and viral pathogens. Genome-wide association analyses were conducted using four analytical approaches
(EIGENSTRAT, EMMAX-GRM, GBLUP and FvR). The most strongly associated SNPs from each individual analysis were
ranked and evaluated for concordance. The heritability of susceptibility to BRDC in pre-weaned Holstein calves
was estimated.
Results: The four statistical approaches produced highly concordant results for 373 top ranked SNPs that defined
126 chromosomal regions for the CA population. Similarly, in NM, 370 SNPs defined 138 genomic regions that
were identified by all four approaches. When the two populations were combined (i.e., CA + NM) and analyzed,
324 SNPs defined 116 genomic regions that were associated with BRDC across all analytical methods. Heritability
estimates for BRDC were 21% for both CA and NM as individual populations, but declined to 13% when the
populations were combined.
Conclusions: Four analytical approaches utilizing both single and multi-marker association methods revealed
common genomic regions associated with BRDC susceptibility that can be further characterized and used for
genomic selection. Moderate heritability estimates were observed for BRDC susceptibility in pre-weaned Holstein
calves, thereby supporting the application of genomic selection to reduce the prevalence of BRDC in U.S. Holsteins.
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Bovine respiratory disease complex (BRDC) is the most
common infectious disease and the leading natural cause
of death among cattle in the United States [1], with the
onset of disease generally considered to be initiated by a
stressful event that suppresses the normal host immune
response, thereby enabling opportunistic viral and bac-
terial infections of the respiratory tract. Many diverse
pathogens can be involved in this process, such that
bovine respiratory disease is considered to be etiologic-
ally complex (i.e., BRDC), and perhaps more challenging
to control or mitigate than many diseases caused by a
single, discrete pathogen. The most common viral path-
ogens associated with BRDC include: bovine herpesvirus 1,
bovine parainfluenza virus 3, bovine viral diarrhea viruses 1
and 2, bovine respiratory syncytial virus, bovine adeno-
viruses A-D, and bovine coronavirus, whereas the most
common bacterial pathogens are Arcanobacterium pyo-
genes, Manheimia haemolytica, Pasteurella multocida,
Histophilus somni, and Mycoplasma spp. [2].
Bovine respiratory disease complex is commonly ob-
served in beef and dairy calves, with both acute and long
term effects on health and performance [3-5]. Acute
effects include production or performance losses asso-
ciated with the symptoms of BRDC that include fever,
rapid breathing, repetitive coughing, nasal and/or eye
discharge, diarrhea, dehydration and appetite depression
[5,6]. The prevalence of BRDC is temporally variable,
with the proportion of affected feedlot cattle ranging
from 5% to 44% over a 15 year period, with an average
overall prevalence of 17% in U.S. feedlots [3,7,8]. In
pre-weaned U.S. dairy calves, the prevalence of BRDC
over a 20 year period ranged from 3.3 to 23.6% [4]. The
mortality rate for BRDC in pre-weaned dairy calves was
22.5%, even though 93.4% of all heifers diagnosed with
BRDC were treated with an antimicrobial agent, and
the majority of these calves were also vaccinated for
one or more known pathogens [4,9]. Chronic effects
of BRDC have resulted in reduced growth rates and
decreased productivity of cows later in life [10,11].
Cows affected by respiratory disease as a calf were
twice as likely to die before calving, and calved at an
older age as heifers, than those cows that were not
affected by BRDC prior to 90 days of age [12,13].
Despite the availability and use of vaccines for common
respiratory pathogens, the prevalence of BRDC in dairy
and beef animals is not declining [7,14,15]. Additional
approaches to reduce the prevalence or prevent BRDC
are needed to positively augment the use of vaccines
and current best management practices aimed at redu-
cing stress. Selection of breeding stock that are less
susceptible to BRDC represents one viable approach
that could be implemented, with the expectation of
systematically reducing BRDC prevalence over the longterm. Previous studies have identified genetic differences
among animals in relation to BRDC susceptibility, thereby
providing ample support and precedent for this hypothesis
and investigation [16-19]. The objective of this study
was to identify loci associated with BRDC susceptibility
in pre-weaned Holstein calves via a case–control study
design. Genome-wide association analyses (GWAA) iden-
tified genomic regions associated with BRDC that were
largely concordant across four analytical approaches.
This level of concordance has not often been reported
in other Holstein GWAA studies that have evaluated
multiple methods [20], which strongly underscores the
potential for genomic selection enabled by BRDC sus-
ceptibility loci reported here. Additionally, heritability
was estimated for BRDC susceptibility in both the indi-
vidual and the combined CA and NM Holstein popu-
lations to further evaluate the potential for reducing




Prior to GWAA, seven of the pre-weaned California
(CA) calves (n = 2021) were removed due to conflicts
with their reported disease status and health scores (i.e.,
recording errors). Likewise, 73 (7.2%) of the control
calves (48 males; 25 females) were later reclassified as
BRDC cases prior to weaning (i.e., they developed clin-
ical signs), and were subsequently removed from the
analysis of the distribution of health scores (Additional
file 1: Table S1). However, these animals did remain in
the GWAA. Consequently, 2,014 calves (1,011 controls
and 1,003 cases) from CA were used in this study. A
total of 766 calves identified as females were enrolled
from New Mexico (NM). Eighteen of the animals were
subsequently identified to be a Jersey or a Jersey cross-
bred and were removed; leaving 748 Holstein identified
heifers in the NM study; 372 as controls and 376 cases.
Six percent of the heifers (n = 23) originally classified as
matched controls later converted to BRDC case-status
but remained in the study, as new diagnostic health
scores and swabs were obtained at the time of conver-
sion. Further details regarding the study animals (age,
gender, proportion of males and females in the cases
and control groups, and diagnostic health scores) may
be found in Additional file 1: Table S1.
Diagnostics
The observed pathogen profiles of the CA and NM
animals differed for all pathogens with the exception of
bovine herpes virus and bovine viral diarrhea virus,
which were rarely detected (P < 0.05) (Table 1). The
detection of different pathogens in CA and NM may
have been influenced by the stage of disease at the time














Arcanobacterium pyogenes 0.3 (0) 10.7 (4.3) 3.1 (1.2) 2.8 1.5-5.3 0.0003
Histophilus somni 1.7 (0.4) 3.2 (0.5) 2.1 (0.4) 4.9 2.0-14.6 <0.0001
Manheimia haemolytica 23.5 (11.1) 4.5 (3.5) 18.4 (9) 2.3 1.8-2.9 <0.0001
Pasteurella multocida 36.3 (23.6) 61.1 (54.8) 43.0 (32) 1.6 1.4-1.9 <0.0001
Mycoplasma spp. 64.6 (57.1) 57.4 (48.7) 62.6 (54.8) 1.4 1.2-1.6 <0.0001
Bovine corona virus 9.6 (7.7) 50.0 (35.0) 19.9 (14.5) 1.5 1.2-1.8 0.0004
Bovine respiratory syncytial
virus
20.8 (7.7) 4.9 (2.5) 16.3 (6.3) 2.9 2.2-3.8 <0.0001
Bovine viral diarrhea virus 0 (0) 1.3 (0) 0.4 (0) NA NA NA
Bovine herpes virus 0 (0) 0 (0) 0 (0) NA NA NA
*Percent of cases and controls (in parentheses) where individual pathogens were present in the pre-weaned Holstein calves. Animals classified as undetermined
with respect to case–control status were not included in the summary statistics presented here.
^Jersey calves (n = 18) were removed;
+Odds ratio of being affected with BRDC when the pathogen was present when the animal was swabbed.
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site. The difference in the mean health scores between
cases and controls (Additional file 1: Table S1) repre-
senting the two populations (i.e., CA vs NM; P < 0.001 in
both populations) may simply reflect local differences in
BRDC disease progression, possibly due to environmen-
tal differences or differences in BRDC pathogen(s) at the
two study sites (Table 1). Notably, viruses that were im-
portant during the initiation of BRDC in Holstein calves
may have been missed since the clinical manifestation of
disease is necessary to identify cases using the McGuirk
scoring system [6]. Moreover, some viruses are only
rarely detected in the bovine pharynx beyond the first
two days of infection (i.e., prior to their migration to the
lung), which may have impacted our diagnostic results.
Because this study occurred in an industry setting, the
timing and certainty of pathogen exposure was un-
known. However, the bacteriology and virology obtained
from mid-nasal and deep pharyngeal swabs in this study
collectively represent the largest ever dairy cattle diag-
nostic survey of respiratory pathogens which are likely
to influence the clinical manifestation of BRDC. This
survey is useful for a variety of reasons, including under-
standing why GWAA signals might potentially differ
between locales, and for understanding the overall diver-
sity in detectable pathogen profiles, as well as their puta-
tive frequency distributions among Holstein calves
classified as BRDC cases and controls [6]. Therefore, the
diagnostic data were helpful in providing a general over-
view of BRDC pathogen diversity at the time of pheno-
type classification (i.e., case vs control), but do not
necessarily provide precise insight into the temporal and
sequential progression of disease with associated patho-
gens across time. Nevertheless, the use of deep pharyngeal
swabs has the very clear advantages of being a much morerapid, less costly, and less invasive sampling technique
than transtracheal washes or bronchioalveolar lavage.Genome wide association analysis
Heritability Estimates. Implementation of EMMAX
[21,22] in conjunction with a genomic relationship matrix
(EMMAX-GRM) [23] and an additive model produced
moderate pseudo-heritability estimates (h2 = 0.21) for
BRDC susceptibility in CA Holstein calves. The pseudo-
heritability, as previously defined h2 ¼ σ2a= σ2a þ σ2e
  
[21], is the proportion of phenotypic variance that is
explained by the empirically estimated relationship matrix.
Although it is not an exact analytical replicate of the
heritability estimate produced by Restricted Maximum
Likelihood Estimation (REML) in the Genomic Best Linear
Unbiased Prediction (GBLUP) analyses, the EMMAX-
GRM pseudo-heritability estimate was very similar to
the GBLUP REML heritability estimate (h2 = 0.21) for
BRDC susceptibility in the California calves. EMMAX-
GRM analyses performed using an additive genetic
model also produced a moderate pseudo-heritability
estimate (h2 = 0.21) for BRDC susceptibility in the NM
calves, which was nearly identical to the GBLUP REML
estimate (h2 = 0.20). In a final analysis, we combined the
NM and CA calves into a single case–control cohort.
EMMAX-GRM pseudo-heritability for BRDC suscepti-
bility within the combined cohort was again moderate
(h2 = 0.13), but considerably lower than the estimates
produced for the individual populations. This result was
supported by the GBLUP REML estimated heritability
for the combined population (h2 = 0.13), which was very
similar to EMMAX-GRM (Table 2).
The heritability estimates of approximately 0.21 for
BRDC susceptibility are greater than similar estimates
Table 2 Heritability estimates of Holstein Calves from
California, New Mexico and California and New Mexico
combined populations
Population h2 VA VE
California-EMMAX-GRM 0.2110 0.0524 0.1959
California-GBLUP 0.2151 0.0535 0.1952
New Mexico-EMMAX-GRM 0.2139 0.0535 0.1966
New Mexico-GBLUP 0.2013 0.0501 0.1988
Combined-EMMAX-GRM 0.1318 0.0328 0.2161
Combined-GBLUP 0.1311 0.0326 0.2162
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ovaries (0.05), ketosis (0.01-0.14), metritis (0.01-0.07) and
lameness (0.02-0.03), but lower than estimates for dis-
placed abomasum (0.32) and retained placenta (0.02-0.36)
previously reported in dairy cows [24-26]. Bovine clinical
mastitis (CM) is similar to BRDC in that a variety of
microorganisms can be involved in the disease etiology.
In CM, heritability estimates increase when the animal
health phenotype is more precisely defined by the spe-
cific microorganism(s) involved in the CM etiology [27].
For example, heritability estimates for susceptibility to
CM caused by Coliform species were found to be mod-
erate (i.e., 0.17-0.19) [27], and similar to our estimates
for BRDC, whereas heritability estimates were lower
when CM cases were pooled (i.e., multiple, unrelated
pathogens), or when CM cases were undetected [27-29],
thereby underscoring the importance of precise animal
disease phenotypes.
Moderate heritability estimates for BRDC suscepti-
bility strongly suggest that there is ample opportunity
to use genomic selection to reduce the prevalence of
BRDC in Holstein dairy cattle. The reduction in herit-
ability estimated for the combined CA and NM cohort,
in comparison to the individual population estimates, is a
complex phenomenon that likely reflects environmental
differences as well as differences in the host genetic basis
for differential susceptibility to a variety of BRDC patho-
gens that were detected at variable frequencies within the
two populations. However, it should also be noted that the
NM calves also tended to be older and presumably more
clinically ill (as defined by the McGuirk Scoring System)
[6] at sampling than did the CA calves, with the majority
of the calves enrolled in the CA study being males, and
nearly all of the calves enrolled in the NM study identi-
fied as being females by Illumina HD genotype (i.e., X
and Y chromosome SNP calls; See Methods). Studies
are currently underway to evaluate the statistical rela-
tionship between pathogen profiles, and the clinical
scores (McGuirk Scoring System) [6] assigned to all
Holstein calves.California population
When the top 2,000 SNPs (i.e., largest effects) for CA
were compared across the four analytical approaches
for the case–control phenotype, a strong concordance
of association with BRDC susceptibility was observed.
Among the top 2,000 SNPs from each analytical approach,
each SNP (or sliding window of 7 SNPs centered on the
third SNP within each window for GBLUP) was given a
ranking (i.e., 1 represented the most significant SNP or
SNP window) and these rankings were summed across
all analytical approaches for each population (Tables 3,
4 and 5). For the CA calves, Figure 1 shows the Manhattan
plots for all analyses (EMMAX-GRM, FvR, GBLUP and
EIGENSTRAT). In CA, the most significant locus across
all four analyses was located on BTA15 between 30–31 Mb
(Table 3). This was also the most significant locus detected
using EMMAX-GRM (P = 2.95 × 10−6, Additional file 1:
Table S2), GBLUP (proportion of additive genetic variance
explained by the window of 7 SNPs or PVE = 0.13; note
these windows slide one SNP at a time and so are not
independent and the sum of PVE for all SNPs is greater
than 1; Additional file 1: Table S3) and FvR (P = 3.74 ×
10−7, Additional file 1: Table S4). The same BTA15
locus was also ranked 30th among SNPs most strongly
associated (P = 2.14 × 10−5) with BRDC susceptibility
using EIGENSTRAT (Additional file 1: Table S5). This
SNP association was supported by 18 adjacent SNPs
ranked among the top 200 SNPs, and 38 SNPs ranked
among the top 2,000 SNPs for either their magnitude of
association or the proportion of variance explained with
respect to BRDC susceptibility. The poliovirus receptor-
related 1 (PVRL1, HGNC: 9706) gene is proximal and
adjacent to this GWAA signal.
PVRL1 is a member of the immunoglobulin super-
family that is known to mediate entry of several herpes
viruses, including bovine herpes virus 1 (BHV-1), the
causative agent of infectious bovine rhinotracheitis
(IBR), which is also a known etiological agent of BRDC
[30]. Notably, BHV-1 was not diagnostically detected in
the mid-nasal or pharyngeal swabs from the CA Holstein
calves, but previous experimental challenge and pathology
studies have demonstrated that many respiratory viruses,
including BHV-1, are only transiently present in the
pharynx prior to settling into the lung (Laurel Gershwin,
personal communication). Therefore, it is unsurprising
that BHV-1 was not detected by our diagnostic proce-
dures, although the host genomic signature of this patho-
gen was clearly detected and well supported statistically by
all GWAA approaches. Our failure to detect BHV-1 likely
reflects the temporal and/or transient differences in viral
expression and pathology (i.e., since the swabs were taken
only at one time point), including latency of the virus in
the trigeminal ganglion, or perhaps other factors, both
known and unknown [31]. BHV-1 causes a lifelong latent
Table 3 Concordance of genome-wide association analyses for the California calves with the loci most strongly
associated with BRDC susceptibility for all analyses
Chromosome (location Mb) EMMAX-GRM+ GBLUP+ FvR+ EIGENSTRAT+ No. SNPs^ Lead SNP# Score*
BTA15 (30–31) 1 1 1 30 18 rs41756356 33
BTA14 (63–64) 14 7 15 6 34 rs134331138 42
BTA3 (119–120) 65 9 7 5 11 rs41660991 86
BTA23 (3–4) 5 2 76 115 5 rs110158528 198
BTA15 (14–15) 156 67 19 3 1 rs136365736 245
BTA19 (9–10) 73 170 37 44 1 rs121919115 324
BTA6 (42–43) 79 21 171 65 12 rs43456007 336
BTA4 (47–48) 74 19 192 63 1 rs41651168 348
BTA14 (11–12) 147 64 3 178 2 rs133522438 392
BTA6 (40–41) 131 72 172 32 12 rs134070398 412
BTA13 (71–72) 45 187 34 155 7 rs110991341 421
BTA7 (10–11) 97 274 135 41 6 rs134195407 547
BTA18 (0–1) 35 313 198 72 32 rs109385868 618
BTA3 (46–47) 178 364 178 31 2 rs133069708 678
BTA2 (45–46) 143 29 287 227 1 rs136772856 686
BTA11 (71–72) 304 375 51 48 1 rs133739594 778
BTA12 (6–7) 76 84 418 210 1 rs135134119 789
BTA3 (107–108) 294 315 98 110 1 rs137396132 817
BTA12 (33–34) 306 176 355 34 1 rs133730139 871
BTA16 (36–37) 125 140 112 529 13 rs136788834 906
BTA6 (95–96) 191 35 82 652 2 rs41911495 960
+Reflects the ranking of the best (lowest) ranked SNP for that genomic region for that analysis. Only scores <1000 are shown.
^Number of SNPs ranked among the top 200 SNPs (top 0.03%) that are found within this genomic region as being associated with BRDC susceptibility across the
different analyses.
#The rs SNP identification number for the SNP with the lowest ranking for the QTL.
*Score is the sum of the ranks for the best ranked SNP for that genomic region across all analyses.
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lead to horizontal transmission to other animals in the
herd. In addition to BRDC, IBR also has the potential
to cause rhinotracheitis, vaginitis, balanoposhitis, abor-
tion, conjunctivitis, and enteritis [32]. Ulcers of BHV-1
infected animals often occur in the mouth and nose,
with mortality as high as 10% [33].
A second locus of interest identified across all analyses
was located on BTA14 between 63–64 Mb. It contained
the 6th ranked SNP by EIGENSTRAT (P = 6.47 × 10−6,
Additional file 1: Table S5), the 7th ranked SNP by GBLUP
(PVE = 0.12, Additional file 1: Table S3), the 14th ranked
SNP by EMMAX-GRM (P < 3.55 × 10−5, Additional file 1:
Table S2), and the 15th ranked FvR SNP (P = 1.09 × 10−5,
Additional file 1: Table S4). This locus was supported by
34 top ranked SNPs, and was located near positional
candidate genes BAALC, ATP6V1C1 and AZIN1.
The most highly ranked SNP in this region across all
analyses was proximal to AZIN1 (antizyme inhibitor 1,
HGNC: 16432), a gene that is involved in many biological
processes, and that is most highly expressed in both lung
and skeletal muscle [34]. AZIN1 has been associated withFanconi’s anemia, tumorogenesis, cirrhosis of the liver,
and regulation of polyamine synthesis [35-37]. The AZIN1
protein (Az1) regulates ornithine decarboxylase stability,
which degrades polyamines, and in turn, up-regulates
AZIN1. Interestingly, ornithine carboxylase activity and
elevated polyamine levels are detected when cells are
transformed by viral agents [38]. Individuals with dele-
terious mutations involving AZIN1 (i.e., qualitative and/
or quantitative) may be more likely to become infected
with viruses, such as hepatitis C [38]. Some mutations in
AZIN1 may also enhance susceptibility to other viruses,
such as those implicated in the clinical manifestation of
BRDC. Flanking genes within this region include brain
and acute leukemia cytoplasmic (BAALC, HGNC: 14333),
and ATPase, H+ transporting, lysosomal 42 kDa, V1 sub-
unit C1 (ATP6V1C1, HGNC: 856). Mutations in BAALC
are implicated in myeloid leukemogenesis, and are associ-
ated with a poor prognosis in acute myeloid leukemia as
well as acute lymphoblastic leukemia [39]. The ATPases
are proton pumps that are involved in a wide variety of
physiological processes [40]. In drosophila, the overex-
pression of V1 subunits was recently found to alter the
Table 4 Concordance of genome-wide association analyses for the New Mexico calves with the loci most strongly
associated with BRDC susceptibility for all analyses
Chromosome (location Mb) EMMAX-GRM+ GBLUP+ FvR+ EIGENSTRAT+ No. SNPs^ Lead SNP# Score*
BTA16 (70–71) 2 3 2 31 10 rs41617348 38
BTA14 (7–8) 5 48 30 7 17 rs109009102 90
BTA18 (65–66) 58 39 62 90 4 rs135115567 249
BTA12 (77–78) 62 30 175 14 1 rs134174086 281
BTA5 (23–24) 1 104 4 192 4 rs109319628 301
BTA13 (56–57) 38 19 184 61 7 rs41630678 302
BTA2 (2–3) 18 65 61 180 31 rs134633034 324
BTA13 (71–72) 112 94 116 38 11 rs133881876 360
BTA16 (64–65) 36 28 36 261 1 rs42692646 361
BTA28 (36–37) 84 23 204 89 2 rs136647452 400
BTA21 (47–48) 88 91 82 144 2 rs134318902 405
BTA25 (22–23) 40 22 98 273 6 rs134095535 433
BTA13 (67–68) 3 6 168 259 6 rs41700634 436
BTA10 (28–29) 145 75 74 167 6 rs136924615 461
BTA17 (72–73) 129 187 178 146 3 rs134357791 640
BTA14 (9–10) 124 179 237 159 2 rs136578677 699
BTA21 (50–51) 73 50 278 322 1 rs133167991 723
BTA19 (26–27) 128 38 81 590 3 rs110385484 837
BTA14 (10–11) 159 344 216 142 5 rs110172337 861
BTA8 (63–64) 194 161 15 491 14 rs43557067 861
BTA13 (6–7) 31 301 389 152 1 rs135796451 873
BTA13 (53–54) 44 82 403 342 13 rs42388964 882
+Reflects the ranking of the best (lowest) ranking SNP for that genomic region for that analysis. Only scores <1000 are shown.
^Number of SNPs ranked in the top 200 SNPs (top 0.03%) that are found in this genomic region as associated with BRDC susceptibility across the
different analyses.
#The rs SNP identification number for the SNP with the lowest ranking for the QTL.
*Score is the sum of the ranking of the best ranking SNP for that genomic region across all analyses.
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ceivable that alteration of V1 subunits could potentially
play a role in the replication capacity of other viruses, such
as those involved in BRDC [41].
The third most significant locus across all analyses for
CA was a 91 kb region defined by 11 SNPs on BTA3 be-
tween 119 and 120 Mb. The SNP rankings for EIGEN-
STRAT, FvR and GBLUP were very similar (i.e., 5th, 7th,
and 9th, respectively), while EMMAX-GRM ranked this
locus 65th (Table 3; Additional file 1: Table S3, Additional
file 1: Table S4, and Additional file 1: Table S5). No an-
notated genes are known to reside in this region of the
genome.
The fourth most significant locus for CA across all ana-
lyses was a 10 kb region on BTA23 between 3 and 4 Mb
(Table 3). This was the 2nd most highly ranked locus
for GBLUP (PVE = 0.13, Additional file 1: Table S3), 5th
for EMMAX-GRM (P = 1.65 × 10−5, Additional file 1:
Table S2), and the 76th and 115th ranked marker forFvR (P = 5.58 × 10−5) and EIGENSTRAT (P = 1 × 10−4),
respectively. The BTA23 SNPs identified as being asso-
ciated with BRDC susceptibility are within an intron
and exon of the dystonin gene (DST or BPAG1, HGNC:
1090). Interestingly, the previously described positional
candidate gene PVRL1 and DST share similar functions, as
they both play a role in herpes virus infections [42,43], one
of the common BRDC pathogens responsible for IBR.
The dystonin protein is essential for anchoring epider-
mal cells to the underlying basement membrane, and dys-
tonin proteins also function as autoantigens in a group of
skin diseases that affect humans [44,45]. Dystonin is also
an integral component of hemidesmosomes, and is regu-
lated by interferon gamma [46]. Relevant to our BRDC
GWAA, dystonin is important in the transport of herpes
simplex virus 1 capsids to the nucleus of the host cell
through the microtubule network [42,43]. Moreover, if the
dystonin protein is depleted, capsid transport and efficient
herpes virus infections are strongly inhibited [42,43].
Table 5 Concordance of genome-wide association analyses for the combined California and New Mexico calves with
the loci most strongly associated with BRDC susceptibility for all analyses
Chromosome (location Mb) EMMAX-GRM+ GBLUP+ FvR+ EIGENSTRAT+ No. SNPs^ Lead SNP# Score*
BTA15 (30–31) 1 1 2 11 16 rs41756356 15
BTA19 (9–10) 40 188 20 1 1 rs121919115 249
BTA15 (31–32) 33 2 299 25 1 rs109057462 359
BTA11 (80–81) 123 103 71 64 9 rs133204524 361
BTA20 (0–1) 30 20 9 315 13 rs110484875 374
BTA3 (46–47) 55 192 91 81 2 rs133069708 419
BTA4 (47–48) 4 36 358 34 18 rs136678678 432
BTA17 (16–17) 26 3 49 397 3 rs135082107 477
BTA3(119–121) 41 339 118 82 3 rs110977672 580
BTA14 (11–12) 142 59 63 319 2 rs133522438 583
BTA17 (14–15) 80 135 26 391 20 rs110488418 632
BTA29 (48–49) 94 171 198 197 1 rs136036800 660
BTA4 (48–49) 21 209 455 3 7 rs110213301 688
BTA20 (0–1) 143 251 170 144 5 rs110513803 708
BTA16 (36–37) 162 280 224 92 14 rs136059947 758
BTA15 (14–15) 182 110 125 354 2 rs136365736 771
BTA3 (89–90) 342 146 138 147 2 rs136571247 773
BTA14 (81–82) 227 371 133 63 6 rs132956286 794
BTA18 (55–56) 107 26 647 26 1 rs136121374 806
BTA12 (58–59) 137 21 593 86 2 rs135900256 837
BTA7 (11–12) 297 207 4 378 1 rs134912653 886
BTA10 (1–2) 284 133 249 267 1 rs136001993 933
BTA17 (10–11) 105 480 100 260 2 rs136672854 945
BTA14 (62–63) 277 613 44 12 1 rs136594328 946
BTA20 (23–24) 60 202 461 254 9 rs109301681 977
+Reflects the ranking of the best (lowest) ranking SNP for that genomic region for that analysis. Only scores <1000 are shown.
^Number of SNPs ranked in the top 200 SNPs (top 0.03%) that are found in this genomic region as associated with BRDC susceptibility across the
different analyses.
#The rs SNP identification number for the SNP with the lowest ranking for the QTL.
*Score is the sum of the ranking of the best ranking SNP for that genomic region across all analyses.
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CA population was on BTA15 between 14–15 Mb (Table 3).
This locus was ranked 3rd (P= 4.28 × 10−6) by EIGEN-
STRAT (Additional file 1: Table S5), 19th by the FvR
approach (P= 1.31 × 10−5, Additional file 1: Table S4), 67th
by GBLUP (PVE= 0.10), and 156th by EMMAX-GRM
(P= 0.003). The associated SNP lies within intron two of
mastermind-like 2 (MAML2) which has been associated with
mucoepidermoid carcinoma, and height in humans [47-49].
New Mexico population
Manhattan plots for the NM calves for all analyses are
shown in Figure 2. The most highly ranked locus across
all GWAA approaches for NM was located on BTA16
between 70 and 71 Mb (Table 4). This locus was defined
by 10 SNPs and contained the second most highly
ranked SNP for FvR (P = 2.93 × 10−6, Additional file 1:Table S4), the second highest ranked SNP for EMMAX-
GRM (P = 1.39 × 10−5, Additional file 1: Table S2), the third
highest ranked SNP for GBLUP (PVE = 0.07, Additional file
1: Table S3) and the 31st ranked SNP for EIGENSTRAT
(P = 2.99 × 10−5). Investigation of the associated region
(105 kb) revealed two uncharacterized loci (LOC
101905027 and LOC101904971; Entrez gene: 101905027
and 101904971) [50], and no annotated genes.
Across all GWAA analyses, the second most highly
ranked locus for NM was located on BTA14 between 7
and 8 Mb and was characterized by 17 SNPs (Table 4).
The 25 kb region was located 2 and 9 kb away from the
transfer RNA glycine (anticodon CCC) (TRNAG-CCC,
Entrez gene: 100126533) and transfer RNA cysteine (anti-
codon ACA) (TRNAC-ACA, Entrez gene: 100499315)
genes, respectively. This region contained the 5th ranked
SNP for EMMAX-GRM (P = 2.97 × 10−5, Additional file 1:
Figure 1 (See legend on next page.)
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Figure 1 Manhattan plots representing four genome wide association analyses for the binary BRDC case–control phenotype using (A)
EMMAX-GRM, (B) GBLUP, (C) EIGENSTRAT and (D) Full versus reduced model regression (FvR) in the CA calves. In panel A, the plot for
EMMAX-GRM case–control with covariates of sex and age is shown. For EMMAX-GRM, the first panel shows the –log10 P-values on the Y axis and
the second panel shows the proportion of variance explained by effects at a single SNP. In panel B, the plot for GBLUP case–control with covariates of
sex and age is shown. The Y axis shows the proportion of variance explained by a sliding window of 7 SNPs centered on the third SNP within each
window. In panel C, the plot for EIGENSTRAT case–control principal component corrected input data (top 100 principle components) with covariates
of sex and age is shown. The –log10 P-values are indicated on the Y axis. The blue line indicates the Wellcome Trust threshold for SNPs with modest
evidence for association with BRDC susceptibility, and the red line indicates the threshold for SNPs with strong evidence for association with
BRDC susceptibility. In panel D, the Manhattan plot for FvR case–control principal component corrected input data (top 53 principal components) with
covariates of sex and age is shown. The first FvR panel shows the –log10 P-values on the Y axis, and the second panel shows corresponding F-test
values for the Full versus Reduced Model Analysis.
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http://www.biomedcentral.com/1471-2164/15/1164Table S2), the 7th ranked SNP for EIGENSTRAT (P= 1.09 ×
10−5, Additional file 1: Table S5), the 30th ranked SNP
for FvR (P = 2.28 × 10−5, Additional file 1: Table S4),
and the 48th ranked SNP for GBLUP (PVE = 0.06).
The third ranked QTL for NM was on BTA18
(65–66 Mb) (Table 4). This region contained the 39th ranked
SNP for GBLUP (PVE= 0.06), the 58th ranked SNP for
EMMAX-GRM (P = 0.001), the 62nd ranked SNP for FvR
(P= 5.69 × 10−5) and the 90th ranked SNP for EIGEN-
STRAT (P= 7.4 × 10−5). This QTL spanning 7.2 kb involved
4 SNPs located in introns 1–3 of the zinc finger protein 850
(ZNF850, HGNC: 27994) gene. At present, little is known
about the function of this gene and protein, which precludes
specific biological inferences in relation to BRDC.
The 4th ranked locus for NM was located on BTA12
(77–78 Mb) (Table 4). This locus was only represented by a
single SNP, and was most highly ranked by EIGENSTRAT
(ranked 14th, P = 1.82 × 10−5, Additional file 1: Table S5).
This locus was ranked 30th by GBLUP (PVE = 0.06,
Additional file 1: Table S3), 62nd by EMMAX-GRM
(P = 0.0001), and 175th by FvR (P = 0.0002). Heparan
sulfate 6-O-sulfotransferase 3 (HS6ST3, HGNC: 19134) is
the only annotated gene in this region. One previous study
suggests that HS6ST3 may perform diverse functions [51],
and more recent studies have associated HS6ST3 with
obesity in humans [52,53].
The 5th ranked locus for NM was located on BTA5,
between 23 and 24 Mb (Table 4). This locus, spanning
3.6 kb, had the highest ranking SNP for EMMAX-GRM
(P = 1.22 × 10−5, Additional file 1: Table S2), ranked 4th
with the FvR approach (P = 6.04 × 10−6, Additional file 1:
Table S4), ranked 104th with GBLUP (PVE 0.06), and
ranked 192nd with EIGENSTRAT (P = 0.0002). No genes
or obvious biological candidates were found in this gen-
omic region, although an expressed sequence tagged
site (EST Bt.86019) [54] detected in bovine kidney
tissue was found to underlie this peak.
Combined California and New Mexico population
When the top 2,000 SNPs (i.e., largest effects) for the
combined population (CA + NM Holstein calves) were
compared across the four analytical approaches for thecase–control phenotype, we noted that the results were
skewed toward those initially reported for the CA popula-
tion (Table 3, Figure 1, Figure 3, Additional file 1: Table S2,
Additional file 1: Table S3, Additional file 1: Table S4,
Additional file 1: Table S5). This was relatively unsur-
prising, as the CA Holstein population had nearly three
times the number of study animals as did the NM popu-
lation, with the top ranked locus for BRDC susceptibility
in the combined population being the same top ranked
locus identified for the CA Holsteins (i.e., positional candi-
date PVRL1, see Table 3). Underlying this QTL signal was
the highest ranked SNP using EMMAX-GRM (P = 1.95 ×
10−5, Additional file 1: Table S2) and GBLUP (PVE = 0.11,
Additional file 1: Table S3), the second highest ranked
SNP for FvR (P = 6.42 × 10−6, Additional file 1: Table S4),
and eleventh ranked SNP for EIGENSTRAT (P = 1.75 ×
10−5, Additional file 1: Table S5).
Across all analyses, the second strongest association
(n = 1 SNP) in the combined cohort was observed on
BTA19 (9–10 Mb) (Table 5). This SNP was the highest
ranked by EIGENSTRAT (P = 5.82 × 10−6, Additional file 1:
Table S5), but was also highly ranked by the FvR approach
(Rank = 20th, P = 1.97 × 10−5, Additional file 1: Table S4),
and by EMMAX-GRM (Rank = 40th, P = 8.91 × 10−5). This
SNP was ranked 188th by GBLUP (PVE = 0.09). The BTA19
SNP associated with BRDC susceptibility is located within
intron 7 of the myeloperoxidase (MPO, HGNC: 7218) gene.
The protein encoded by MPO is central to the activity of
neutrophils, and sputum myeloperoxidase is recognized as
a putative biomarker for neutrophil activity in pulmonary
disease [55].
For the combined cohorts (CA and NM), the third
highest ranked locus across all analyses was represented
by a single SNP located on BTA15 (31–32 Mb) (Table 5).
This SNP was the second highest ranked SNP by GPLUP
(PVE= 0.10, Additional file 1: Table S3), the 25th ranked
SNP by EIGENSTRAT (P= 4.04 × 10−5, Additional file 1:
Table S5), the 33rd ranked SNP by EMMAX-GRM (P= 6.9 ×
10−5), and the 299th ranked SNP by FvR (P = 0.003). At
present, no annotated genes have been described within
50 kb of this SNP, thereby precluding the identification
of one or more suitable positional candidate genes.
Figure 2 (See legend on next page.)
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Figure 2 Manhattan plots representing four genome wide association analyses for the binary BRDC case–control phenotype using (A)
EMMAX-GRM, (B) GBLUP, (C) EIGENSTRAT and (D) Full versus reduced model regression (FvR) in NM calves. In panel A, the plot for
EMMAX-GRM case–control with covariates of sex and age is shown. For EMMAX-GRM, the first panel shows the –log10 P-values on the Y axis and
the second panel shows the proportion of variance explained by effects at a single SNP. In panel B, the plot for GBLUP case–control with covariates of
sex and age is shown. The Y axis shows the proportion of variance explained by a sliding window of 7 SNPs centered on the third SNP within each
window. In panel C, the plot for EIGENSTRAT case–control principle component corrected input data (top 5 principal components) with the covariate
age is shown. In panel C, the –log10 P-values are on the Y axis. The blue line indicates the Wellcome Trust threshold for SNPs with modest evidence
for association with BRDC susceptibility, and the red line indicates the threshold for SNPs with strong evidence for association with BRDC susceptibility.
In panel D, the Manhattan plot for FvR case–control principal component corrected input data (top 9 principal components) with covariates of sex
and age is shown. The first FvR panel shows the –log10 P-values on the Y axis, and the second panel shows corresponding F-test values for the
Full versus Reduced Model Analysis.
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cohort (CA + NM) was located on BTA11 (80–81 Mb),
and was ranked 64th among the results obtained using
EIGENSTRAT (P = 8.42 × 10−5, Table 5), 71st using FvR
(P = 5.33 × 10−5), 103rd using GBLUP (PVE = 0.09), and
123rd using EMMAX-GRM (P = 0.0002). The most prox-
imal gene to this SNP is retinol dehydrogenease 14
(all-trans/9-cis/11-cis) (RDH14, HGNC: 19979), which
is located approximately 13 kb away. This gene encodes a
mitochondrial protein that recognizes retinoids as sub-
strates and may protect the mitochondria from oxidative
stress associated with exposure to retinaldehyde [56].
The fifth ranked locus identified by all methodological
approaches revealed a strong positional candidate gene
on BTA20 (0–1 Mb) that is supported by 13 SNPs and
spans 19 kb (Table 5). This QTL was identified by SNPs
among the top 30 ranked for FvR (ranked 9th, P = 1.32 ×
10−5 Additional file 1: Table S4), GBLUP (ranked 20th,
PVE = 0.10; Additional file 1: Table S3) and EMMAX-
GRM (ranked 30th, P = 6.02 × 10−5, Additional file 1:
Table S2). This SNP was ranked 315th by EIGENSTRAT
(P = 0.0004). The most strongly associated SNPs were
located within introns 2 and 10 of the slit homolog 3
(SLIT3, HGNC: 11807)) gene [57]. SLIT3 is a very large
gene spanning 727 kb. The protein encoded by SLIT3
has numerous functions, one of which includes the down
regulation of inflammatory mediators such as IL-1β, Il-6
and IL-8 [58]. SLIT3 has also been implicated in cell
migration, axon guidance, inflammation, angiogenesis
and organogenesis [59]. The SLIT family of proteins
features a tandem of four leucine-rich repeat domains
which mediate binding to the immunoglobulin-like
domains of the Roundabout (Robo) family of genes [60].
SLIT-Robo signaling has been implicated in immune re-
sponse through the regulation of dendritic cell migration
[61]. Airway dendritic cells are key regulators of pulmon-
ary immune responses, and in the human lung, dendritic
cells continuously present antigenic information from the
airways to the pulmonary lymph nodes, thereby modulat-
ing the regulation of immune responses [62]. Therefore,
perturbations of bovine SLIT3 function may also influencesusceptibility to BRDC, making it a plausible functional
candidate gene for future investigations.
Conclusions
Differences existed in the CA and NM Holstein calf
populations in the ages of the calves when sampled, the
average McGuirk health score [6] of the cases and con-
trols, and the gender of the calves. These differences
were incorporated into the analysis models to account
for age and gender of the calves. The differences be-
tween the CA and NM pathogens detected at sampling
likely had an impact on the BRDC susceptibility loci de-
tected in the calves.
The BRDC heritability estimate of 0.21 for CA and
NM calves was consistent across the two populations,
but dropped to 0.13 when the populations were com-
bined. This decline is most likely due to pathogen and
environmental differences at the two study sites. How-
ever, the moderate heritability (0.13) estimated for BRDC
susceptibility in the combined Holstein population is
sufficient to support a nation-wide approach to reduce
the prevalence of BRDC via genomic selection. Although
each of the methods used to conduct the GWAA have
strengths and weaknesses, the concordance between the
loci associated with BRDC susceptibility across the four
approaches has resulted in the identification of loci that
are strong candidates for harboring causal mutations,
and these QTL signals are less likely to have arisen solely
by type 1 error. Several biologically meaningful positional
candidate loci were identified in this study. Among these
positional candidates are genes on BTA15 (PVRL1) and
BTA23 (DST) that are known to mediate herpes virus
entry into host cells, a gene involved in viral susceptibility
on BTA14 (AZIN1), and a gene that modulates inflamma-
tion on BTA20 (SLIT3). Studies in Bos taurus feedlot
cattle are currently underway to determine if some of
the same loci are associated with enhanced susceptibility
to BRDC in older cattle from different breeds.
Selection and breeding of less susceptible cattle with
respect to BRDC is the most sustainable approach to
reducing the prevalence of disease, as it will decrease
Figure 3 (See legend on next page.)
Neibergs et al. BMC Genomics 2014, 15:1164 Page 12 of 19
http://www.biomedcentral.com/1471-2164/15/1164
(See figure on previous page.)
Figure 3 Manhattan plots representing four genome wide association analyses for the binary BRDC case–control phenotype using (A)
EMMAX-GRM, (B) GBLUP, (C) EIGENSTRAT and (D) Full versus reduced model regression (FvR) in the CA and NM calves combined. In
panel A, the plot for EMMAX-GRM case–control with covariates of sex, age, and herd of origin is shown. For EMMAX-GRM, the first panel shows
the –log10 P-values on the Y axis and the second panel shows the proportion of variance explained by effects at a single SNP. In panel B, the plot
for GBLUP case–control with covariates of sex and age is shown. The Y axis shows the proportion of variance explained by a sliding window of 7
SNPs centered on the third SNP within each window. In panel C, the plot for EIGENSTRAT case–control principle component corrected input data
(top 80 principal components) with covariates of sex and age is shown. The –log10 P-values are indicated on the Y axis. The blue line indicates
the Wellcome Trust threshold for SNPs with modest evidence for association with BRDC susceptibility, and the red line indicates the threshold for
SNPs with strong evidence for association with BRDC susceptibility. In panel D, the Manhattan plot for FvR case–control principal component
corrected input data (top 91 principal components) with covariates of sex, age, and herd of origin is shown. The first FvR panel shows the –log10 P-values
on the Y axis, and the second panel shows corresponding F-test values for the Full versus Reduced Model Analysis.
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tion efficiency, require less handling, and ultimately be
more profitable. Studies are currently underway to identify
the causal mutations associated with enhanced BRDC sus-
ceptibility, as an alternative to relying on array-based SNP
markers as imperfect predictors of these mutations. More-
over, unlike approaches that rely on markers in linkage
disequilibrium (LD) with the causal mutations for gen-
omic selection, the accuracy of utilizing causal mutations
to predict susceptibility will not decay over time, and likely
will have utility across breeds, which enhances the value
and longevity of the final marker panel to the industry.
Identification of the causal mutations underlying BRDC
QTL will ensure that the initial work of this study is sus-
tainably translated to industry, with QTLs associated with
enhanced BRDC susceptibility providing the foundation
for identifying causal mutations with the largest effects on
susceptibility, so that these may be incorporated into pre-
dicted transmitting abilities (PTA) for commercial dairy
artificial insemination (AI) sires. As greater than 70% of
the dairy calves in the U.S. are conceived by AI annually
[63] this will provide immediate translation of our discov-
eries to a large segment of the U.S. dairy industry.
Methods
Study population
This study was conducted with an approved animal use
protocol from the Institutional Animal Care and Use Com-
mittees at the University of California at Davis (16431),
Washington State University (04110), New Mexico State
University (2011–010), Texas A&M University (2014–0032)
and the University of Missouri (7505). California Holstein
calves were enrolled in a case–control study from July
2011 through January 2012. Collectively, 2,014 calves
were enrolled as cases (n = 1,003) and controls (n = 1,011),
with 1,257 males and 757 females. Animals in New
Mexico were enrolled from August 2011 through June
2012 in a case control study at three calf raising facilities
within the Clovis and Portales areas of New Mexico. All
study animals were identified as heifers in the field, and
consisted of 372 controls and 376 cases. The animals weresampled such that the proportions of cases and controls
were almost identical across seasons of the year and
locations in order to eliminate these effects as sources
of variation in the experimental design. Details on the
calf raising facilities, and the management and vaccin-
ation of the calves are specified in Additional file 1.
BRD and control calf determination
Calves treated with antibiotics within 10 days prior to
study onset were not considered for enrollment since
treatment could facilitate negative bacterial cultures.
Calves younger than 22 days of age were not enrolled to
avoid potential false positive results during viral diagnos-
tic tests (i.e., real time quantitative PCR, qPCR) due to
the modified-live vaccines administered at 1 and 8 days
of age [64]. Calves housed in hutches between the ages
of 27 and 60 days of age were closely monitored and
considered for enrollment as either BRDC cases or con-
trols, based on the assignment of calf health scores using
a respiratory screening tool developed by McGuirk [6].
Calves were observed before feeding (in the early morn-
ing) and assigned a health score as follows: 0 for normal, 1
for slightly abnormal, 2 for abnormal, and 3 for severely
abnormal, with a numeric score also assigned for rectal
temperature, cough, nasal discharge, eye discharge, and
ear tilt as previously described [6]. The ability to induce a
cough was assessed by entering the calf hutch and apply-
ing pressure to (while massaging) the bovine larynx. A calf
with a cumulative score ≥ 5 was enrolled in the study as a
BRDC case, and immediately thereafter, a calf adjacent to
the BRDC case that possessed a cumulative score ≤ 3 was
enrolled as a matched control. If no adjacent calf was suit-
able, the closest calf in the same row was enrolled as a
matched control. Other observed clinical signs (though
not included in the scoring system) were status for depres-
sion, dyspnea, tachypnea, and watery diarrhea, given the
presence of fresh stool. Once enrolled, calves were
assigned a case number and the hutch was labeled for
subsequent monitoring. After enrollment, calves were
observed and scored daily for clinical signs of BRDC. If
a previously enrolled control calf converted to a BRDC
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control to a case and two new matched control and case
calves were enrolled.
Sample collection
Each day after completion of respiratory scoring, with
identification of cases and matched controls, a veterinarian
and facility personnel returned to those animals to collect
samples. All case and control calves had nasopharyngeal
and pharyngeal recess swabs collected for qPCR diagnos-
tics, and a second pharyngeal recess swab was collected
for aerobic bacteria and mycoplasma respiratory pathogen
culturing. Samples collected from the nasopharyngeal re-
gion utilized a six-inch sterile unguarded polyester swab
that was inserted five inches into a clean naris and rotated
against the surface for 15 seconds. Thereafter, the swab
was removed and cut ¼ inch above the polyester tip, and
placed into 3 ml of viral transport media (minimum essen-
tial media, HCO3, HEPES, Gentamycin, Amphotericin B).
Pharyngeal recess swabbing utilized a 27-inch sterile
guarded swab with a polyester fiber tip (Kalajian Indus-
tries, Signal Hill CA 90755). The distance from the nose
to the medial canthus of the eye was measured and
marked as a gauge on the guarded swab. The swab was
inserted through a nostril into the ventral meatus and then
advanced toward the pharyngeal recess until reaching the
gauge mark at the external naris. The swab was then
pushed to open the guarding cap and advanced approxi-
mately two inches, rotated against the pharyngeal recess
surface for 15 seconds, retracted back into the guarding
sheath, and removed from the nose. The swab was cut
two inches above the polyester tip, and placed into the
same tube of viral transport media containing the naso-
pharyngeal swab. A second deep pharyngeal swab was
placed into 1 ml of bacterial transport media (Brucella
broth with 15% glycerol) for the detection of bacteria.
All samples were stored on wet ice in the dark until
completion of sampling and delivery to the lab. Scissors
used to cut individual swabs were disinfected with a
dilute Povidone iodine solution, and dried before each
use. Bacterial samples were submitted daily for bacterial
respiratory pathogen culture to either the California
Animal Health and Food Safety lab system (CAHFS, Tulare
CA Branch) for the CA samples, or to the Washington
Animal Disease Diagnostic Laboratory at Washington
State University (WADDL, Pullman, WA) for the NM
samples. Viral qPCR samples from CA and NM were
stored at −80°C until submission and processing at the
CAHFS Davis Branch. Whole blood and serum were
also collected for use in the GWAA studies.
Analyses of animal data
The difference in mean age of groups of calves was tested
using a t-test. Likewise, health scores between calf groupswere investigated for differences using the Wilcoxon
Rank-Sum test. To test whether the proportions of cases
in groups of males and females were unequal, the standard
test for two binomial proportions with continuity correc-
tion was used. All statistical tests were two-tailed tests
with significance thresholds of P = 0.05 and were per-
formed in R. A detailed summary of all tests is provided in
the Additional file 1. The findings reported in Additional
file 1 indicate that age and gender had an effect on suscep-
tibility to BRDC, and therefore, were included in the
GWAA models. Neither season nor month of sampling
had an effect on BRDC susceptibility, and thus were not
included in the GWAA models.
To date, conflicting results have emerged regarding
the potential influence of gender on susceptibility to
BRDC. Male beef calves have been reported to be more
susceptible to BRDC than female calves, both at pre-
weaning (14.4% compared to 9.5%) and post-weaning
(17.2% compared to 12.5%) [17]. In the feedlot, Gallo
and Berg [65] found that male calves were more likely to
relapse (P = 0.0015) and be chronically affected (P = 0.03)
with BRDC than females, and Cusack et al. [66] found
that steers were more likely (P = 0.03) to die in the feedlot
due to BRDC than were cows. In contrast, Ribble et al.
[67] found that heifers were at a higher risk of death from
BRDC than male calves, but in this study, the heifers were
purchased in smaller groups than were their male coun-
terparts, which may have impacted their risk for death.
Finally, Sanderson et al. [68] reported no gender differ-
ences with respect to BRDC susceptibility, indicating a
lack of unity within the established literature regarding the
impact of gender on risk, and therefore, gender should be
included within GWAA models for BRDC.
Aerobic bacteria and Mycoplasma culture and qPCR
Culturing for aerobic respiratory pathogens allowed for
the identification of the following important bacterial
species: Histophilus somni, Pasteurella multocida, Biberstei-
nia trehalosi, Mannheimia haemolytica. The culture and
qPCR of bacteria and mycoplasma for samples derived
from the CA calves were conducted at the California Animal
Health and Food Safety Laboratory System (University
of California Veterinary Medicine Teaching and Research
Center in Tulare, California). Similar samples obtained
from the NM calves were processed using standardized
procedures at WADDL (Pullman, WA). Additional aerobic
culture methods are presented in the Additional file 1.
Virology
Diagnostics for bovine corona virus, bovine respiratory
syncytial virus, bovine viral diarrhea virus and bovine
herpes virus type I were conducted from an aliquot of
3 ml of transport media (previously described) contained
in 5 ml cryotubes that housed a mid-nasal and deep
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into the cryotubes immediately post collection and kept
on ice until they reached the laboratory where they were
frozen until analyzed. For the diagnostic analysis, samples
were thawed and an aliquot of the transport media was
removed for use in the qPCR diagnostics. Diagnostics were
performed at the University of California Animal Health
and Food Safety Laboratory System in Davis California.
Analyses of diagnostic data
The estimated odds ratio for BRDC pathogens and case
status (inclusive of the 95% confidence intervals for the
estimated odds ratio) were calculated in R. A two-tailed
Fisher’s exact test was used to determine if the odds ratios
differed significantly from 1, with a significance threshold
of P = 0.05.
Bovine DNA isolation
Bovine DNA was isolated from 3 ml of whole blood col-
lected in EDTA tubes using the Puregene DNA extraction
kit, according to the manufacturer’s instructions (Gentra,
Minneapolis, MN). DNA samples were quantified using
NanoDrop (Wilmington, DE), spectrophotometry and
purity was estimated using the 260/280 ratio. Samples
with 260/280 ratios between 1.8 and 2.0 were diluted to
50 ng/μl, and 250 ng of each calf ’s DNA was genotyped
using the Illumina BovineHD Genotyping Beadchip at
GeneSeek (Lincoln, NE). The Illumina (San Diego, CA)
BovineHD Beadchip assay [69] contained 777,962 SNPs, with
mean and median intermarker spacing of one SNP every
3.43 and 2.68 kb across the bovine genome, respectively.
Heritability estimation
For the GBLUP analyses, custom developed software was
used to generate the genomic relationship matrix [23] and
to fit a generalized linear mixed model incorporating fixed
effects and a random additive genetic merit effect for each
individual. The software incorporates the inverse of the gen-
omic relationship matrix and iterates on REML estimates of
additive genetic and residual variance components until the
heritability estimate has converged to a user-defined preci-
sion (P < 0.0005 here). At this point, GBLUP estimates of
SNP effects were estimated as the regression of SNP effects
on additive genetic merits as described by Taylor [70].
Pseudo-heritability h2 ¼ σ2a= σ2a þ σ2e
  
[21] was similarly
estimated using a genomic relationship matrix [23], with
REML estimates of variance components, as previously de-
scribed and implemented in Python [22].
Genome-wide association analyses
Susceptibility to BRDC was treated as a binary trait based
on the classification of the health scores obtained from the
McGuirk [6] scoring system taken at the time of samplecollection from the calves. The GWAA was conducted
using four analytical approaches: 1) Efficient Mixed-
Model Association eXpedited-genomic relationship matrix
(EMMAX-GRM) [21,22], 2) Full versus Reduced model
(FvR) regression using principle component analysis-
corrected input data within SNP & Variation Suite 7
(SVS; Golden Helix, Bozeman) [71], 3) GBLUP [70], and 4)
EIGENSTRAT [72].
Using the binary BRDC case–control phenotype, the
EMMAX-GRM analyses were conducted using an additive
model and consisted of single marker tests of association
[21], with corresponding estimates for the proportion of
variance explained (PVE) by effects at single markers, and
utilized a genomic relationship matrix [23], rather than
an IBS kinship matrix [21,22]. EMMAX-GRM analyses
treated additive effects at X-linked loci in a different
manner to those of autosomal loci, which has previously
been suggested [70]. Specifically, within an additive
model, hemizygous males may only possess 0 or 1 copy
of an X-linked minor allele (excluding the pseudoauto-
somal region), whereas females may possess 0, 1, or 2
copies of the minor allele. A gender correction reflecting
these ploidy differences was utilized to recode X-linked
genotypes prior to EMMAX-GRM analyses. All EMMAX-
GRM analyses were coded in Python [22,73,74] and were
executed in the SVS environment (Golden Helix, version
7.7.6), thereby allowing for simultaneous data visualization
and exploration while also providing a Python shell that
allows for modification of scripts, as needed (i.e., REML
versus ML variance component estimates, etc.). Briefly,
the general mixed model can be specified as: y =Xβ + Zu
+ ϵ, where y is an n × 1 vector of the observed phenotypes,
X is a n × q matrix of fixed effects, β is a q × 1 vector
representing the levels of the fixed effects, and Z is a n × t
matrix relating the instances of the random effect to the
phenotypes. Herein, we assume that Var uð Þ ¼ σ2gK and
Var Þ ¼ σ2e I

, such that Var yð Þσ2gZKZ0 þ σ2e I , but in this
study, Z is simply the identity matrix I, and K is the matrix
of pairwise genetic relationships among all samples. To
solve the mixed model equations using the generalized least




must first be estimated (21–22). We used the REML-based
EMMA approach to estimate the variance components
as previously described [75], with stratification among
all Holstein dairy calves accounted for and controlled
using a GRM [23] computed from the filtered Illumina
778 K genotypes. Individual EMMAX-GRM analyses for
NM and CA included both sex and age as covariates. Like-
wise, for our analysis of the combined cohort (NM+CA),
both sex and age were again treated as covariates, but we
also included a population of origin variable as a third and
final covariate (Additional file 2: Figure S1). All relevant
formulae are also available online (http://doc.goldenhelix.
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lix.com/SVS/latest/mixed_models.html).
The FvR regression analysis utilized the binary BRDC
case–control phenotype as the dependent variable within
an additive model, with all genotypes recoded numerically
based on the copy number of the minor allele. Recoding
also included the same ploidy-based gender correction for
X-linked loci described for the EMMAX-GRM procedure
above. We corrected for population stratification using
principal components analysis (PCA), with PCA-based
correction of the input data using established methods
[72,76]. To identify a reasonable number of principal com-
ponents for correction of the input data, we first estimated
the Genomic Inflation Factor Lambda (λ) [77] across
increasing numbers of principal components for each
Holstein population, with 9 (NM), 53 (CA) and 91 (CA +
NM) principal components yielding Inflation Factors (λ)
of 1.06, 1.12, and 1.06, respectively. Thereafter, we imple-
mented the FvR method, which consists of using two
regression models commonly referred to as: A) the re-
duced model and B) the full model; with the significance
of the genetic marker estimated after removing the effects
of covariates by performing a full versus reduced model
analysis. The reduced model included only the dependent
variable (BRDC binary case–control status) and any
potentially confounding covariates (i.e., the covariates
sex, age, or population of origin variable in the com-
bined NM + CA cohort). The full model included all of
the variables plus the effect of each genetic marker
individually. For the “full versus reduced” linear regres-
sion model (i.e., FvR), the regression sums of squares
were calculated both for the reduced and for the full
model. An F test was performed to find the significance










The P-value is calculated by: P-value = P(X > F*) where
X ~ (m-r,n-m), with m and r being the rank of the full
and reduced model coefficient matrices, respectively,
and n being the number of observations. All relevant
formulae for PCA correction of input data, the FvR
method, and recoding procedures have previously been
described [71,78]. For all FvR regression analyses, we
used the following covariates: NM (sex, age), CA (sex,
age), Combined cohort NM + CA (sex, age, population
of origin variable) (Additional file 3: Figure S2). All PCA
correction [72] and FvR regression analyses were per-
formed in the SVS environment (Golden Helix, version





In the GBLUP analyses, we fit the model yijk = μ +
Sexi + βAgej + ak + eijk where yijk is a binary variable set
to 1 for cases and 0 for controls of the ith sex (i = male,
female), jth age (in days) and with additive genetic merit
for susceptibility to BRDC of ak. The eijk are residuals
assumed identically and independently distributed with
null mean and for e = {eijk} we assumed Var(e) = Iσ2eÞ .
For a = {ak} we assumed Var(a) = Gσ2a where G is the gen-
omic relationship matrix [23,70]. Variance components σ2a
and σ2e were estimated by restricted maximum likelihood
and at convergence of the variance component estimates,
SNP effects were estimated by GBLUP as the regression
of SNP effects on additive genetic merits as described in
Taylor [69]. The GBLUP analysis also included X-linked
SNP using the approach described in [69]. Previous ana-
lyses using the software have been published including
Decker et al. [79] and McClure et al. [80].
EIGENSTRAT [72] is a method for analysis of associ-
ation between genotype and phenotype that corrects for
stratification using a principal components approach.
Principal component analysis is applied to genotype data
to infer axes of genetic variation. Genotypes and pheno-
types are subsequently adjusted using the top principal
components. The adjusted genotype (gij adjusted) for each
principal component is computed by:







where gij denotes genotype of individual j at SNP i and
aj denotes ancestry of individual j along a given principal
component. The phenotypic adjustment is similarly
computed for each principal component as:







Finally, the association between the adjusted genotypes
and phenotypes is tested using the test statistic:
X2 ¼ N−K−1ð Þr2i
where ri is the correlation between the adjusted geno-
type at SNP i (gij, adjusted) and the adjusted phenotype
(pj, adjusted), N is the number of individuals, and K is the
number of principal components used for adjustment. This
test statistic is χ2 distributed with one degree of freedom.
In order to correct for the stratification in the geno-
typic data, the first (top) 100, 5, and 80 principal compo-
nents were used in the EIGENSTRAT analysis of California,
New Mexico, and the combined data sets, respectively. The
use of these principal components also corrected for the
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the calves (Additional file 4: Figure S3, Additional file 5:
Figure S4). As a result, the Genomic Inflation Factor
Lambda (λ) values declined to 1.08 in CA, 1.09 in NM,
and 1.09 in the CA-NM combined data. Sex and age
were fit in the model for CA, age was fit in the model
for NM and sex, age was fit in the model for the com-
bined population (Additional file 6: Figure S5).
Significance for all association tests (i.e., EMMAX-
GRM, FvR, EIGENSTRAT) was based on the recommen-
dation of the Wellcome Trust Case Control Consortium
[81] where unadjusted P-values less than 5 × 10−7 were
considered to provide strong evidence of association, and
unadjusted P-values between 5 × 10−5 and 5 × 10−7 were
considered to provide moderate evidence for association.
Individual analyses were conducted for the CA and
NM populations, with final analyses that included the
combined cohort (NM + CA). For comparisons of the
top SNPs and loci identified across the four analytical
approaches, the top ranked 2,000 SNPs from each of the
four analytical approaches were identified and compared.
SNPs were ranked either by P value (EIGENSTRAT,
EMMAX-GRM and FvR) or by PVE (GBLUP) from 1
(most significant SNP) to 2,000. For comparisons of SNPs
that were associated with BRDC susceptibility across all
statistical methodologies (EIGENSTRAT, EMMAX-GRM,
FvR and GBLUP) as shown in Tables 3, 4 and 5, the rank-
ing of the SNP in each method was summed to arrive at
a composite ranking. SNPs with a composite ranking
that was less than 1000 across all methods are provided
in Tables 3, 4 and 5.
QTL were defined by the number of top ranked SNPs
that were associated with BRDC susceptibility for a gen-
omic region within each statistical method. For example,
if a single SNP within a region was among the top
ranked SNPs, the locus would be defined by the single
SNP. However, if several highly ranked SNPs were in
close proximity to one another, the QTL would be de-
fined by the chromosomal location of the outermost
SNPs in that region. An example of this would be the
QTL on BTA4 (48–49 Mb) in the CA +NM population
where the QTL is defined by 7 SNPs within the region
48,052,484 to 48,149,487 bp.Additional files
Additional file 1: Supplementary Information. Table S1. Distribution of
pre-weaned Holstein calf health scores (McGuirk 2008). Table S2. Top 30
ranked bovine SNPs by the EMMAX-GRM analyses of the California, New
Mexico and combined populations. Table S3. Top 30 ranked bovine SNPs
for GBLUP analyses of California, New Mexico and combined populations.
Table S4. Top 30 ranked bovine SNPs resulting from the FvR analyses of
California, New Mexico and the combined populations. Table S5. Top 30
ranked bovine SNP for EIGENSTRAT analyses of California, New Mexico and
combined populations.Additional file 2: Figure S1. EMMAX-GRM P-P plots with age and sex
in the model for: A. California, and B. NM. In panel C., sex, age and population
of origin were included in the combined CA-NM population. For each of the
plots in panels A-C, the observed –log10 P-value (on the Y axis) is plotted
against the expected –log10 P-value (on the X axis).
Additional file 3: Figure S2. FvR P-P plots with sex and age in the
model for: A. California with correction for 53 principle components, and
B. NM calves with correction of 9 principle components. In panel C. sex,
age and population of origin were included in the combined CA-NM
population which included correction of 91 principle components. For
each of the plots in panels A-C, the observed –log10 P-value (on the Y
axis) is plotted against the expected –log10 P-value (on the X axis).
Additional file 4: Figure S3. The first four EIGENSTRAT principal
component analyses plots showing the distribution of presumed
half-siblings (based on the genomic relationship matrix) of ten sires
with the most offspring within the California calf study population.
Each sire’s offspring are coded with a different color and tend to cluster
together within the study population. In panel A., the first principal
component (PC1) (plotted on the X axis) is compared against the second
principal component (PC2)( on the Y axis). In panel B., PC1 is again plotted
on the X axis but is now compared against the third principal component
(PC3) on the Y axis. Principal component 2 (PC2) (on the X axis) is plotted
against the third principal component (PC3)( on the Y axis) in panel C. In
Panel D., PC1 (on the X axis) was plotted against principal component 4
(PC4) (on the Y axis). In panel E., PC2 (on the X axis) was compared to PC4
(on the Y axis). Finally, in panel F., PC1 was plotted (on the X axis) and
compared to PC4 (on the Y axis).
Additional file 5: Figure S4. The first four EIGENSTRAT principal
component analyses plots showing the distribution of presumed half-siblings
(based on the genomic relationship matrix) of the ten sires with the
most offspring within the New Mexico calf population. Each sire’s
offspring are coded with a different color and tend to cluster together
within the study population. In panel A., the first principal component
(PC1) (plotted on the X axis) is compared against the second principal
component (PC2)( on the Y axis). In panel B., PC1 is again plotted on the
X axis but is now compared against the third principal component (PC3)
on the Y axis. Principal component 2 (PC2) (on the X axis) is plotted
against the third principal component (PC3)( on the Y axis) in panel C.
In Panel D., PC1 (on the X axis) was plotted against principal component
4 (PC4) (on the Y axis). In panel E., PC2 (on the X axis) was compared to
PC4 (on the Y axis). Finally, in panel F., PC1 was plotted (on the X axis)
and compared to PC4 (on the Y axis).
Additional file 6: Figure S5. EIGENSTRAT Q-Q plots: A. CA with
correction of 100 principle components and age and sex included in the
model, B. NM calves with correction of 5 principle components with only
age included in the model, and C. the combined CA-NM population with
correction of 80 principle components and sex and age included in the
model. For each of the plots in panels A-C, the observed –log10 P-value
(on the Y axis) is plotted against the expected –log10 P-value (on the X axis).
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